Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼

Monday, January 25, 2010

Pharma press release: re Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives

"Our ultimate goal is to secure a strategic partnership to support further development of picoplatin in CRC and other solid tumor indications, including prostate and ovarian cancers.'"

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.